Precise sphincter-saving surgery for early rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a refined surgical method for removing rectal tumors while preserving the anal sphincter, which may help avoid a permanent colostomy. It is for patients with early-stage rectal cancer that is close to the anus and has not spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have rectal cancer that is moderately or well differentiated (not poorly differentiated).
- The lower edge of your tumor is within 5 cm of the anal opening.
- Your tumor is at an early stage (T1 to T3) and has not spread to distant organs like the lungs or liver.
- You do not have other cancers or severe health conditions that would make surgery risky.
- Your anal function is good enough for surgery that aims to keep the anus intact.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two surgical approaches to remove rectal cancer while preserving bowel function. Researchers want to see which method—performed through the anus or with robotic assistance—leads to better outcomes and quality of life.
This trial tests how well a precise surgery removes the remaining rectal cancer after you have had radiation and chemotherapy. It is for people whose tumor has shrunk a lot but is still there, and the tumor is very low in the rectum.
This trial compares two ways to protect the healing connection in your bowel after rectal cancer surgery. One method uses a thin tube placed through your nose down to the small intestine to divert stool away from the surgery site before the operation, while the other creates a temporary opening in the abdomen (an ileostomy) during the surgery. The goal is to see if the tube works as well as the ileostomy in preventing leaks and improving recovery.
This trial tests a treatment plan that combines chemotherapy, immunotherapy, and radiation before surgery for patients with middle or low rectal cancer. The goal is to shrink the tumor enough to avoid removing the anus, preserving bowel function.
This trial compares two surgical techniques to remove low rectal cancer while aiming to preserve bowel control. It may help you keep better anal function after surgery.
This trial tests three different surgical methods for rectal cancer located very close to the anal canal. The goal is to see which method works best in the short and long term while preserving anal function.
Hear when a new Low Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.